Clinical Trials Logo

Healthy Subjects clinical trials

View clinical trials related to Healthy Subjects.

Filter by:

NCT ID: NCT01884636 Completed - Healthy Subjects Clinical Trials

A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of Methotrexate

Start date: February 2013
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the effect of multiple doses of isavuconazole on the pharmacokinetics of a single dose of methotrexate. Safety and tolerability of isavuconazole will be assessed alone and in combination with methotrexate.

NCT ID: NCT01884558 Completed - Healthy Subjects Clinical Trials

A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of Metformin

Start date: February 2013
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the effect of multiple doses of isavuconazole on the pharmacokinetics of a single dose of metformin. Safety and tolerability of isavuconazole will be assessed alone and in combination with metformin.

NCT ID: NCT01883544 Completed - Healthy Subjects Clinical Trials

Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ALXN1007 in Healthy Male and Female Subjects

Start date: June 2013
Phase: Phase 1
Study type: Interventional

The purpose of the study is to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of multiple intravenous (IV) doses of ALXN1007 in healthy male and female subjects.

NCT ID: NCT01883284 Completed - Cystic Fibrosis Clinical Trials

Action of Epigenetic Modifiers in Cystic Fibrosis Treatment

Mod2EpiCF
Start date: January 2012
Phase: N/A
Study type: Interventional

Epigenetic modifiers has been showed to rescue F508del-CFTR channel to apical membrane of epithelial cell lines. In this study, the investigators evaluate epigenetic modifiers effects firstly on CFTR rescue, then on secretion and synthesis of inflammatory factors (IL-8, LXA4 and SCGB1A1) and mucines (MUC5AC and MUC5B) in a dynamic epithelium model using an air-liquide interface culture of nasals cells from CF patients or controls.

NCT ID: NCT01877629 Completed - Healthy Subjects Clinical Trials

Clinical Study to Assess the Pharmacokinetics, Safety, and Tolerability of ACT-129968 in Healthy Subjects

Start date: July 1, 2011
Phase: Phase 1
Study type: Interventional

To explore the pharmacokinetics (PK) of a single dose of two different formulations of ACT-129968, i.e., tablet versus capsule and to evaluate the safety and tolerability of a single dose of two different formulations of ACT-129968, i.e., tablet versus capsule.

NCT ID: NCT01877304 Completed - Healthy Subjects Clinical Trials

Effect of Drug Targeting Nebulization on Lung Deposition

Start date: June 2010
Phase: N/A
Study type: Interventional

To compare deposition between two modalities of nebulization

NCT ID: NCT01872806 Completed - Healthy Subjects Clinical Trials

Electrophysiological Reactivity Due to Mobile Phone Radiation

Start date: June 2013
Phase: N/A
Study type: Interventional

The main objective of this study is to investigate whether radiofrequency electromagnetic radiation, induced by a dialing mobile phone placed on the body, causes a change in electrophysiology.

NCT ID: NCT01866215 Completed - Healthy Subjects Clinical Trials

Effects of Exercise on Fructose Metabolism

FruEx2
Start date: May 2013
Phase: N/A
Study type: Interventional

A high fructose diet increases fasting and post-prandial triglyceride (TG) concentrations in sedentary healthy human subjects.These effects may be secondary to fructose-induced hepatic de novo lipogenesis. Recent evidence indicate that exercise can prevent fructose induced dyslipidemia.This study will evaluate 1. how exercise effects the metabolic fate of oral fructose 1a) when exercise is performed before fructose ingestion 1b) when exercise is performed after fructose ingestion Metabolic effects of exercise will be assessed in healthy male subjects by measuring fructose oxidation (13CO2 production), fructose conversion into glucose (13C glucose concentrations in blood) and hepatic fructose conversion into lipid (13C palmitate-very low density lipoprotein (VLDL) concentrations in blood) after ingestion of 13C-labelled fructose meals 2. how fructose and protein modulate muscle glycogen and intramyocellular lipid repletion after exercise Healthy male subjects will be fed various fructose, glucose, lipid and whey protein meals after a glycogen/intramyocellular lipid depleting exercise. The effects of meals' composition will be assessed after 24 hours by measuring intramyocellular lipids and glycogen using proton-magnetic resonance spectroscopy (MRS).

NCT ID: NCT01862601 Completed - Healthy Subjects Clinical Trials

JetTouch Injection System to Deliver Saline Into the Bladder Wall of Healthy Volunteers

Start date: September 2013
Phase: Phase 1
Study type: Interventional

This research study is being done to see how well the JetTouch Needle-Free Endoscopic Injection System is able to deliver a solution safely into the bladder wall. The JetTouch Needle-Free Endoscopic Injection System is a jet injector that allows fluids to be injected into the bladder without using a needle. It is hoped that this method will provide a reliable and consistent method to deliver drugs into the bladder wall.

NCT ID: NCT01840865 Completed - Healthy Subjects Clinical Trials

Effects of Brain Stimulation During Daytime Nap on Memory Consolidation in Younger, Healthy Subjects

Start date: October 2013
Phase: N/A
Study type: Interventional

The beneficial effect of daytime sleep on memory consolidation has been shown in young, healthy subjects. Especially, periods rich in slow-wave sleep (SWS) have shown a memory enhancing effect on hippocampus-dependent declarative memory. Slow oscillatory activity typically occuring during SWS has been implicated in the consolidation effect. In this study we investigate if the consolidation effect can be amplified by the application of a weak transcranial oscillatory electric current within the frequency range of SWS in humans (0,7-0,8 Hz) during daytime SWS.